Table 2.
Distribution of the androgen receptor polymorphisms in controls and preeclampsia cases
| Control | Preeclampsia | P-value | |||||
|---|---|---|---|---|---|---|---|
| n | (%) | n | (%) | ||||
| CAG repeat | |||||||
| Median (range) | 20 (13–26) | 20 (13–29) | 0.357 | ||||
| GGC repeat | |||||||
| Median (range) | 16 (11–18) | 16 (12–22) | 0.279 | ||||
| c.211 G>A genotype | |||||||
| GG | 162 | 85.3 | 137 | 74.4 | reference | ||
| GA | 28 | 14.7 | 41 | 22.3 | 0.032 | ||
| AA | 0 | 0 | 6 | 3.3 | – | ||
| GA/AA | 28 | 14.7 | 47 | 25.6 | 0.010 | ||
| c.211 G>A allelic distribution | |||||||
| G | 352 | 92.4 | 315 | 85.6 | reference | ||
| A | 28 | 7.6 | 53 | 14.4 | 0.003 | ||